Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
76.41 USD | -0.68% | -0.04% | -30.23% |
May. 22 | CONMED Keeps Quarterly Dividend at $0.20 a Share, Payable July 5 to Shareholders of Record June 14 | MT |
May. 22 | CONMED Corporation Declares Quarterly Cash Dividend, Payable on July 5, 2024 | CI |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The company is in debt and has limited leeway for investment
- The company is not the most generous with respect to shareholders' compensation.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-30.23% | 2.35B | B- | ||
-2.26% | 187B | C+ | ||
+2.05% | 110B | C | ||
-1.31% | 69.54B | A | ||
+14.65% | 46.37B | B- | ||
-6.69% | 46.05B | B- | ||
+7.97% | 42.54B | B+ | ||
+18.60% | 30.72B | B | ||
-6.87% | 23.32B | B | ||
-10.63% | 22.92B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CNMD Stock
- Ratings CONMED Corporation